Tag: DiaMedica Therapeutics

December 31, 2018

4 Life Science IPOs in December

December brought four life science IPOs on the NASDAQ, giving investors new opportunities to enter the market.
December 7, 2018

DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

DiaMedica Therapeutics (NASDAQ:DMAC) (TSXV:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering in the...
September 27, 2018

DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke

Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,...
May 1, 2017

DiaMedica Granted US Patent for DM199

DiaMedica Therapeutics received a patent for DM199 from the US Patent and Trademark Office.
April 13, 2017

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...